PSCRO May 3, 2020 Articles Abstract Abstract unavailable. Please download related documents below. PSCRO.2020.8e1001 (May 1, 2020) Elena Zuber, Diana Schweitzer, Dominick Allen, Seema Parte, and Sham S. Kakar Download Full Text Download Full Article PDF DOI: 14343/PSCRO.2020.8e1001 Tags: Pranela Rameshwar Continue Reading Previous PostChallenges in Leveraging Cancer Stem Cell Properties for Therapeutic Development You Might Also Like High expression of miR-9 in CD133 C glioblastoma cells in chemoresistance to temozolomide February 27, 2015 Methods for efficient transduction of cancer stem cells December 1, 2014 Distinct molecular signature of recurrent ovarian tumor cells isolated from the ascites of advanced-stage serous ovarian cancer patients November 26, 2014
High expression of miR-9 in CD133 C glioblastoma cells in chemoresistance to temozolomide February 27, 2015
Distinct molecular signature of recurrent ovarian tumor cells isolated from the ascites of advanced-stage serous ovarian cancer patients November 26, 2014